دورية أكاديمية
Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus.
| العنوان: | Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus. |
|---|---|
| المؤلفون: | Jean-Pierre V; Service de Microbiologie et Hygiène hospitalière, HydroSciences Montpellier, Univ. Montpellier, CNRS, IRD, CHU de Nîmes, Montpellier, 34093, France., Sorlin P; CPias Loire Atlantique, CHU de Nantes, Nantes, 44093, France., Jeannot K; Laboratoire associé du Centre National de Référence de la Résistance aux Antibiotiques, CHU de Besançon, Besançon, 25000, France., Chiron R; Centre de Ressources et de Compétences de la Mucoviscidose, HydroSciences Montpellier, Univ. Montpellier, CNRS, IRD, CHU de Montpellier, Montpellier, 34093, France., Lavigne JP; Service de Microbiologie et Hygiène hospitalière, VBIC, INSERM U1047, Univ. Montpellier, CHU de Nîmes, Nîmes, 30900, France., Pantel A; Service de Microbiologie et Hygiène hospitalière, VBIC, INSERM U1047, Univ. Montpellier, CHU de Nîmes, Nîmes, 30900, France., Marchandin H; Service de Microbiologie et Hygiène hospitalière, HydroSciences Montpellier, Univ. Montpellier, CNRS, IRD, CHU de Nîmes, Montpellier, 34093, France. helene.marchandin@umontpellier.fr. |
| المصدر: | Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2024 Aug 22; Vol. 23 (1), pp. 78. Date of Electronic Publication: 2024 Aug 22. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711 (Electronic) Linking ISSN: 14760711 NLM ISO Abbreviation: Ann Clin Microbiol Antimicrob Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2002]- |
| مواضيع طبية MeSH: | Achromobacter*/drug effects , Microbial Sensitivity Tests*/methods , Anti-Bacterial Agents*/pharmacology , Cephalosporins*/pharmacology , Cefiderocol*, Humans ; Gram-Negative Bacterial Infections/microbiology |
| مستخلص: | Background: Cefiderocol is a siderophore-conjugated cephalosporin increasingly used in the management of Achromobacter infections. Testing for cefiderocol susceptibility is challenging with distinct recommendations depending on the pathogens. Objectives: We evaluated the performance of commercial tests for testing cefiderocol susceptibility in the Achromobacter genus and reviewed the literature. Methods: Diffusion (disks, MIC gradient test strips [MTS], Liofilchem) and broth microdilution (BMD) methods (ComASP™, Liofilchem; UMIC ® , Bruker) were compared with the BMD reference method according to the EUCAST guidelines on 143 Achromobacter strains from 14 species with MIC Results: None of the methods tested fulfilled an acceptable essential agreement (EA). MTS displayed the lowest EA (30.8%) after UMIC ® (49%) and ComASP™ (76.9%). All methods achieved an acceptable bias, with MICs either underestimated using MTS (-1.3%) and ComASP™ (-14.2%) or overestimated with UMIC ® (+ 9.1%). Inhibition zone diameters ranged from 6 to 38 mm (IZD Conclusions: The use of MTS is discouraged for Achromobacter spp. Disk diffusion can be used to screen for susceptible strains by setting a threshold diameter of 30 mm. UMIC ® and ComASP™ should not be used as the sole method but have to be systematically associated with disk diffusion to detect the yet rarely described cefiderocol-resistant Achromobacter sp. strains. (© 2024. The Author(s).) |
| References: | Ann Clin Microbiol Antimicrob. 2024 Jun 17;23(1):54. (PMID: 38886694) Clin Infect Dis. 2021 Oct 5;73(7):e1754-e1757. (PMID: 33313656) Infect Drug Resist. 2022 Oct 10;15:5887-5897. (PMID: 36237292) J Antimicrob Chemother. 2022 May 29;77(6):1662-1669. (PMID: 35289853) Diagn Microbiol Infect Dis. 2019 Aug;94(4):321-325. (PMID: 31029489) J Clin Microbiol. 2020 Dec 17;59(1):. (PMID: 32938734) Ann Intensive Care. 2023 Jun 15;13(1):52. (PMID: 37322293) Antibiotics (Basel). 2023 Mar 17;12(3):. (PMID: 36978470) Antibiotics (Basel). 2022 Oct 04;11(10):. (PMID: 36290010) Antibiotics (Basel). 2021 Oct 27;10(11):. (PMID: 34827247) Microorganisms. 2023 Jul 31;11(8):. (PMID: 37630529) Antibiotics (Basel). 2023 Jul 20;12(7):. (PMID: 37508308) IDCases. 2020 Jun 03;21:e00863. (PMID: 32577400) Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):559-566. (PMID: 38240988) Antimicrob Agents Chemother. 2020 Apr 21;64(5):. (PMID: 32071053) J Appl Lab Med. 2023 May 4;8(3):523-534. (PMID: 36738243) Lancet Infect Dis. 2021 May;21(5):597-598. (PMID: 33894839) Antibiotics (Basel). 2023 Mar 20;12(3):. (PMID: 36978482) Antimicrob Agents Chemother. 2023 Dec 14;67(12):e0034623. (PMID: 37971240) Clin Microbiol Infect. 2022 Aug;28(8):1156.e1-1156.e5. (PMID: 35533970) Front Cell Infect Microbiol. 2022 Dec 05;12:1048633. (PMID: 36544909) Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988) Microbiol Spectr. 2023 Dec 12;11(6):e0535522. (PMID: 37855593) Eur J Clin Microbiol Infect Dis. 2024 Jun;43(6):1171-1179. (PMID: 38652417) Microbiol Spectr. 2024 Mar 5;12(3):e0295323. (PMID: 38315029) J Antimicrob Chemother. 2023 Jul 5;78(7):1672-1676. (PMID: 37209112) Clin Microbiol Infect. 2023 May;29(5):652.e1-652.e8. (PMID: 36587736) Microbiol Spectr. 2023 Dec 12;11(6):e0237123. (PMID: 37966262) Antimicrob Agents Chemother. 2020 Oct 20;64(11):. (PMID: 32816734) Pediatr Pulmonol. 2020 Nov;55(11):2990-2994. (PMID: 32662948) Rev Esp Quimioter. 2022 Sep;35 Suppl 2:20-27. (PMID: 36193981) J Antimicrob Chemother. 2023 Jul 5;78(7):1800-1801. (PMID: 37141286) J Microbiol Methods. 2024 Aug;223:106972. (PMID: 38871227) Microorganisms. 2021 Nov 30;9(12):. (PMID: 34946075) |
| فهرسة مساهمة: | Keywords: Achromobacter; Cefiderocol; Diffusion; Disk; Microdilution; Susceptibility testing |
| المشرفين على المادة: | 0 (Anti-Bacterial Agents) 0 (Cephalosporins) SZ34OMG6E8 (Cefiderocol) |
| تواريخ الأحداث: | Date Created: 20240822 Date Completed: 20240823 Latest Revision: 20240825 |
| رمز التحديث: | 20240826 |
| مُعرف محوري في PubMed: | PMC11342684 |
| DOI: | 10.1186/s12941-024-00731-1 |
| PMID: | 39175015 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1476-0711 |
|---|---|
| DOI: | 10.1186/s12941-024-00731-1 |